| Q36904906 | Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL |
| Q98576550 | Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study |
| Q57811225 | Archetypal Arg169Cys Mutation in NOTCH3 Does Not Drive the Pathogenesis in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leucoencephalopathy via a Loss-of-Function Mechanism |
| Q64934926 | Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau. |
| Q30861866 | CADASIL and CARASIL. |
| Q37948174 | Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review |
| Q89827667 | Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia |
| Q50100193 | Differential diagnosis between sarcoidosis and granulomatosis with polyangiitis in a patient with leptomeningeal, cavernous sinus and pituitary lesions. |
| Q89388330 | Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders |
| Q33669397 | Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model |
| Q89143734 | Efficacy of Endovascular Therapy in Acute Ischemic Stroke Depends on Age and Clinical Severity |
| Q49495227 | Elevated ALS Biomarker Levels in CSF of a FTD Patient at the Presymptomatic Stage of ALS. |
| Q50044362 | Endovascular management of extracranial occlusions at the hyperacute phase of stroke with tandem occlusions. |
| Q90728907 | Increased PKR level in human CADASIL brains |
| Q92910974 | Intracranial Extension of Extracranial Vertebral Dissection Is Associated With an Increased Risk of Ischemic Events |
| Q89250231 | Neurosarcoidosis: leptomeninigeal, cavernous sinus and pituitary involvement |
| Q35128837 | Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease. |
| Q37713541 | Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice. |
| Q57811238 | Response to Letter Regarding Article, “Archetypal Arg169Cys Mutation in NOTCH3 Does Not Drive the Pathogenesis in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leucoencephalopathy via a Loss-of-Function Mechanism” |
| Q50096608 | Visibility of Blood Flow on Optical Coherence Tomography Angiography in a Case of Branch Retinal Artery Occlusion. |
| Q64983497 | What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France. |
| Q85188668 | [Severe dysautonomia revealing Wernicke's encephalopathy] |